Dunhill Financial LLC Invests $31,000 in Omega Healthcare Investors, Inc. (NYSE:OHI)

Dunhill Financial LLC bought a new stake in Omega Healthcare Investors, Inc. (NYSE:OHI) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 766 shares of the real estate investment trust’s stock, valued at approximately $31,000.

Several other hedge funds also recently modified their holdings of the stock. UMB Bank n.a. grew its stake in shares of Omega Healthcare Investors by 353.4% in the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 516 shares in the last quarter. True Wealth Design LLC bought a new stake in Omega Healthcare Investors in the third quarter valued at approximately $31,000. DiNuzzo Private Wealth Inc. acquired a new stake in shares of Omega Healthcare Investors in the third quarter valued at approximately $33,000. V Square Quantitative Management LLC boosted its stake in shares of Omega Healthcare Investors by 49.5% during the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock worth $40,000 after acquiring an additional 323 shares during the period. Finally, Truvestments Capital LLC acquired a new position in shares of Omega Healthcare Investors during the 3rd quarter worth approximately $43,000. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Stock Down 0.5 %

Shares of OHI opened at $39.25 on Monday. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10. Omega Healthcare Investors, Inc. has a 12 month low of $27.53 and a 12 month high of $44.42. The firm’s 50 day moving average is $40.48 and its 200-day moving average is $37.69. The stock has a market capitalization of $10.60 billion, a PE ratio of 28.86, a P/E/G ratio of 1.22 and a beta of 0.98.

Omega Healthcare Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were paid a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.83%. Omega Healthcare Investors’s dividend payout ratio (DPR) is presently 197.06%.

Insiders Place Their Bets

In other news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This represents a 10.96 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 36.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Wells Fargo & Company reaffirmed an “overweight” rating and set a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Royal Bank of Canada lifted their target price on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a report on Monday, November 11th. Berenberg Bank began coverage on shares of Omega Healthcare Investors in a report on Friday, October 18th. They issued a “buy” rating and a $45.00 price target on the stock. BMO Capital Markets raised their price objective on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research report on Monday, October 7th. Finally, Scotiabank upped their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research report on Monday, August 26th. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, Omega Healthcare Investors has a consensus rating of “Hold” and an average price target of $40.18.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.